Brian Newman
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
UPS Expands Philippines Hub Amid Record-High Shipping Prices. United Parcel Service opened a larger air hub in the Philippines with 170 weekly flight segments to boost Asia service levels. Meanwhile, the company is navigating a peak shipping season marked by record-high delivery prices and stacking surcharges. These operational expansions and pricing dynamics are key focal points for market watchers assessing the company's trajectory.
Transaction History
| CL | ▲ Buy | Grant | 209 | $19K | 7/1/2026 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 2,478 | $225K | 5/31/2026 | View on chart |
| CL | ▲ Buy | Grant | 2,075 | $0 | 5/11/2026 | View on chart |
| CL | ▲ Buy | Grant | 210 | $19K | 4/1/2026 | View on chart |
| CVS | ▲ Buy | Grant | 19,493 | $1.4M | 3/31/2026 | View on chart |
| CL | ▲ Buy | Grant | 238 | $19K | 1/2/2026 | View on chart |
| CL | ▲ Buy | Grant | 228 | $19K | 10/1/2025 | View on chart |
| CL | ▲ Buy | Grant | 208 | $19K | 7/1/2025 | View on chart |
| CVS | ▲ Buy | Grant | 21,861 | $1.4M | 5/31/2025 | View on chart |
| CL | ▲ Buy | Grant | 2,019 | $0 | 5/12/2025 | View on chart |
| CL | ▲ Buy | Grant | 203 | $19K | 4/1/2025 | View on chart |
| CL | ▲ Buy | Grant | 201 | $19K | 1/2/2025 | View on chart |
| CL | ▲ Buy | Grant | 178 | $19K | 10/1/2024 | View on chart |
| CL | ▲ Buy | Grant | 196 | $19K | 7/1/2024 | View on chart |
| CL | ▲ Buy | Grant | 1,587 | $0 | 5/13/2024 | View on chart |
| CL | ▲ Buy | Grant | 212 | $19K | 4/1/2024 | View on chart |
| UPS | ▲ Buy | Option Exercise | 26,847 | $0 | 2/16/2024 | View on chart |
| UPS | ▲ Buy | Option Exercise | 4,064 | $0 | 2/16/2024 | View on chart |
| UPS | ▼ Sell | Tax Withholding | 1,823 | $270K | 2/16/2024 | View on chart |
| UPS | ▼ Sell | Tax Withholding | 12,070 | $1.9M | 2/16/2024 | View on chart |
| UPS | ▼ Sell | Other | 6,582 | $0 | 8/10/2023 | View on chart |
| UPS | ▼ Sell | Other | 6,582 | $0 | 8/10/2023 | View on chart |
| UPS | ▼ Sell | Other | 17,500 | $0 | 5/30/2023 | View on chart |
| UPS | ▼ Sell | Other | 4,036 | $0 | 5/30/2023 | View on chart |
| UPS | ▼ Sell | Other | 17,500 | $0 | 5/30/2023 | View on chart |
| UPS | ▼ Sell | Other | 4,036 | $0 | 5/30/2023 | View on chart |
| UPS | ▼ Sell | Other | 11,677 | $0 | 2/21/2023 | View on chart |
| UPS | ▼ Sell | Other | 15,713 | $0 | 2/21/2023 | View on chart |
| UPS | ▼ Sell | Other | 4,036 | $0 | 2/21/2023 | View on chart |
| UPS | ▼ Sell | Tax Withholding | 36,588 | $6.4M | 2/17/2023 | View on chart |
| UPS | ▲ Buy | Option Exercise | 81,125 | $0 | 2/17/2023 | View on chart |
| UPS | ▼ Sell | Tax Withholding | 2,147 | $397K | 2/17/2023 | View on chart |
| UPS | ▼ Sell | Open Market | 19,000 | $3.5M | 2/17/2023 | View on chart |
| UPS | ▲ Buy | Option Exercise | 4,758 | $0 | 2/17/2023 | View on chart |
| UPS | ▼ Sell | Other | 19,000 | $0 | 2/17/2023 | View on chart |
| UPS | ▼ Sell | Other | 19,000 | $0 | 2/17/2023 | View on chart |
| UPS | ▼ Sell | Other | 9,287 | $0 | 5/31/2022 | View on chart |
| UPS | ▼ Sell | Other | 9,287 | $0 | 5/31/2022 | View on chart |
| UPS | ▲ Buy | Option Exercise | 5,244 | $0 | 2/18/2022 | View on chart |
| UPS | ▼ Sell | Tax Withholding | 2,039 | $450K | 2/18/2022 | View on chart |
| UPS | ▼ Sell | Gift | 25,000 | $0 | 2/17/2021 | View on chart |
| UPS | ▼ Sell | Gift | 25,000 | $0 | 2/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Colgate-Palmolive dividend focus ahead of Q3 earnings call
Recent coverage lists Colgate‑Palmolive as a dividend champion and a contender for income‑focused investors. The company will host its 2026 third‑quarter earnings webcast on October 30, where results and guidance are expected. Investors noting the upcoming November 13 dividend should be aware of the October 20 record date to qualify for the payment. The stock continues to trade with a dividend yield of about 2.5%.
Colgate-Palmolive dividend focus ahead of Q3 earnings call. Recent coverage lists Colgate‑Palmolive as a dividend champion and a contender for income‑focused investors. The company will host its 2026 third‑quarter earnings webcast on October 30, where results and guidance are expected. Investors noting the upcoming November 13 dividend should be aware of the October 20 record date to qualify for the payment. The stock continues to trade with a dividend yield of about 2.5%.